Cynosure Group, LLC
Source: SEC Form 13F · as of Mar 2026Cynosure Group, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $9.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$9.2M
| Company | Shares | Value |
|---|---|---|
| GEHCGE HealthCare Technologies Inc. | 20,645 | $1.6M |
| JNJJOHNSON & JOHNSON | 2,204 | $539K |
| PTGXProtagonist Therapeutics, Inc | 4,635 | $489K |
| INSMINSMED Inc | 2,947 | $482K |
| BBIOBridgeBio Pharma, Inc. | 6,460 | $480K |
| LQDALiquidia Corp | 12,318 | $465K |
| PTCTPTC THERAPEUTICS, INC. | 6,728 | $458K |
| KNSAKiniksa Pharmaceuticals International, plc | 9,331 | $449K |
| RPRXRoyalty Pharma plc | 9,276 | $445K |
| AXSMAxsome Therapeutics, Inc. | 2,617 | $442K |
| MIRMMirum Pharmaceuticals, Inc. | 4,694 | $434K |
| KRYSKrystal Biotech, Inc. | 1,649 | $426K |
| ELANElanco Animal Health Inc | 17,670 | $423K |
| IONSIONIS PHARMACEUTICALS INC | 5,614 | $422K |
| GMOptec International, Inc. | 5,610 | $418K |
| LGNDLigand Pharmaceuticals Incorporated | 2,085 | $416K |
| IDXXIDEXX LABORATORIES INC /DE | 740 | $416K |
| ROIVRoivant Sciences Ltd. | 14,360 | $398K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.